Product Description
All proceeds from this notebook benefit The Weekend to End Breast Cancer to support research into finding a cure…. More >>
» Read more: Breast Cancer Journal Engage Books
Product Description
All proceeds from this notebook benefit The Weekend to End Breast Cancer to support research into finding a cure…. More >>
» Read more: Breast Cancer Journal Engage Books
One in five people with lung cancer have small cell lung cancer and only three per cent of these people are expected to survive for five years. With this form of lung cancer, tumours spread quickly so it is rarely possible to remove the tumours surgically. Because of this, small cell lung cancer is treated with chemotherapy, with or without additional radiotherapy. Initially, the treatment often appears to work, reducing the size of the tumours. However, the tumours usually grow back rapidly and then become resistant to further treatment.
The researchers behind today’s study have identified a drug that, in some mice, was able to completely shrink tumours away. In the mouse models, it was also able to stop tumours from growing and it helped other forms of chemotherapy to work more effectively. If the drug proves successful in humans, the researchers hope that it could help patients with this kind of lung cancer to live longer.
» Read more: Drug Shrinks Lung Cancer Tumors In Mice
BioSante plans new prostate cancer drug testing
BioSante Pharmaceuticals Inc. said Monday it hopes to restart testing of an experimental prostate cancer drug almost two years after the research was stopped.
Read more on AP via Yahoo! Finance